These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 37723519)

  • 1. COL5A2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer based on transcriptomics and single-cell RNA sequencing.
    Chen M; Zhu X; Zhang L; Zhao D
    BMC Med Genomics; 2023 Sep; 16(1):220. PubMed ID: 37723519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer Based on Bioinformatic Analysis.
    Lin Y; Zhang L; Zhang X; Wei X; Liu X; Xie Y; Han G
    J Environ Pathol Toxicol Oncol; 2023; 42(4):61-68. PubMed ID: 37522568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying Diagnostic and Prognostic Biomarkers and Candidate Therapeutic Drugs of Gastric Cancer Based on Transcriptomics and Single-Cell Sequencing.
    Zhao X; Wu S; Jing J
    Pathol Oncol Res; 2021; 27():1609955. PubMed ID: 34899080
    [No Abstract]   [Full Text] [Related]  

  • 5. Integrated single-cell RNA sequencing analysis reveals a mesenchymal stem cell-associated signature for estimating prognosis and drug sensitivity in gastric cancer.
    Shen K; Chen B; Gao W
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11829-11847. PubMed ID: 37410142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Core Prognosis-Related Candidate Genes in Chinese Gastric Cancer Population Based on Integrated Bioinformatics.
    Li M; Wang X; Liu J; Mao X; Li D; Wang Z; Tang Y; Wu S
    Biomed Res Int; 2020; 2020():8859826. PubMed ID: 33381592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of COL5A2, a member of COL5 family, indicates the poor survival and facilitates cell migration in gastric cancer.
    Tan Y; Chen Q; Xing Y; Zhang C; Pan S; An W; Xu H
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33739392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptomic characterization and construction of M2 macrophage-related prognostic and immunotherapeutic signature in ovarian metastasis of gastric cancer.
    Gao J; Zhao Z; Zhang H; Huang S; Xu M; Pan H
    Cancer Immunol Immunother; 2023 May; 72(5):1121-1138. PubMed ID: 36336725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ENTPD1-AS1-miR-144-3p-mediated high expression of
    Yuan HM; Pu XF; Wu H; Wu C
    World J Gastrointest Oncol; 2023 Jul; 15(7):1182-1199. PubMed ID: 37546560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of biomarkers for epithelial-mesenchymal transition-related cells to estimate the prognosis and immune microenvironment in primary gastric cancer by the integrated analysis of single-cell and bulk RNA sequencing data.
    Shen K; Ke S; Chen B; Zhang T; Wang H; Lv J; Gao W
    Math Biosci Eng; 2023 Jun; 20(8):13798-13823. PubMed ID: 37679111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated analysis of single-cell and bulk RNA-sequencing reveals a novel signature based on NK cell marker genes to predict prognosis and immunotherapy response in gastric cancer.
    Sun JR; Kong CF; Ye YX; Wang Q; Qu XK; Jia LQ; Wu S
    Sci Rep; 2024 Apr; 14(1):7648. PubMed ID: 38561388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty Acid Metabolism Signature Contributes to the Molecular Diagnosis of a Malignant Gastric Cancer Subtype with Poor Prognosis and Lower Mutation Burden.
    Chen Z; Cheng G
    Recent Pat Anticancer Drug Discov; 2024; 19(5):666-680. PubMed ID: 37691229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of pivotal genes associated with the prognosis of gastric carcinoma through integrated analysis.
    Ma Z; Xu J; Ru L; Zhu W
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33754626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 9‑gene expression signature to predict stage development in resectable stomach adenocarcinoma.
    Liu Z; Liu H; Wang Y; Li Z
    BMC Gastroenterol; 2022 Oct; 22(1):435. PubMed ID: 36241983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cuproptosis-related gene SERPINE1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer.
    Feng L; Li G; Li D; Duan G; Liu J
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10851-10865. PubMed ID: 37318594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer.
    Deng H; Li T; Wei F; Han W; Xu X; Zhang Y
    Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965
    [No Abstract]   [Full Text] [Related]  

  • 18. Discovery of a novel lipid metabolism-related gene signature to predict outcomes and the tumor immune microenvironment in gastric cancer by integrated analysis of single-cell and bulk RNA sequencing.
    Zhang J; Wang H; Tian Y; Li T; Zhang W; Ma L; Chen X; Wei Y
    Lipids Health Dis; 2023 Dec; 22(1):212. PubMed ID: 38042786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a CD8+ T cell associated signature for predicting the prognosis and immunological characteristics of gastric cancer by integrating single-cell and bulk RNA-sequencing.
    Li J; Han T; Wang X; Wang Y; Yang R; Yang Q
    Sci Rep; 2024 Feb; 14(1):4524. PubMed ID: 38402299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Analysis of the Expression and Prognosis for ITGBs: Identification of ITGB5 as a Biomarker of Poor Prognosis and Correlated with Immune Infiltrates in Gastric Cancer.
    Liu D; Liu S; Fang Y; Liu L; Hu K
    Front Cell Dev Biol; 2021; 9():816230. PubMed ID: 35223869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.